Paul,
Hard to know what profits it will make on the orders. I listened to the Conf Call a second time and they mentioned they helped their clients acquire needed materials during SARS and H1N1, albeit on a smaller scale. I have not followed the company in the past to know what impact that had on their revenue stream.
They are researching products and creating what they believe to be reliable pipelines for products for their healthcare customers on a large scale of orders. Still not clear whether orders and shipments then become direct from supplier/manufacturer to client or somehow via WORX. Also not mentioned on the call was what revenue WORX expects or whether they charge for the service they are providing etc. So hard to know.
I'm assuming they are getting a % of the order amounts, but until the company clarifies, we don't know what a $35M order for test kits means to WORX P/L sheet.
Maybe someone can approach the company to find out.
What seems clear from call is that this is not the first time they have done something along these lines. Just that because of the massive scale of the needs in light of the pandemic, they created a new subsidiary division called "DIRECT WORX" to handle the procurement and supply chains and the escrow account etc. to be able to do what they are doing now on behalf of hospitals and healthcare systems.